Click here to create your personal news page. The news that appears on Biotechnologies will appear there and be constantly updated. You can then modify the page, share it with your friends, or export it and have it appear elsewhere.

You can also create a personal news page and follow the news that interests you by clicking on the tab labelled 'New page'.
 

topics : related - allExplore

Wikio Shopping (beta)

  1. 1. Automotive
  2. 2. Beauty & Fragrances
  3. 3. Car/Motor Bike
  4. 4. Clothing, Accessories & Shoes
  5. 5. Communication
  6. 6. Computers
  7. 7. Electronics
  8. 8. Flowers & Gifts
  9. 9. Gourmet & Foods
  10. 10. Health & Personal Care
  11. 11. Home & Garden
  12. 12. Household Appliances
  13. 13. Jewelry & Watches
  14. 14. Musical Instruments
  15. 15. Sports & Outdoors
  16. 16. Toys & Baby
  17. 17. Video Games

New products

  1. 1. Western Digital ShareSpace 4 TB
  2. 2. Sapphire Radeon HD 4550
  3. 3. LG KP500
  4. 4. Dell S2309W
  5. 5. Samsung Pixon
  6. 6. Shuttle D 1000H
  7. 7. Philips M200
  8. go to Shopping

Participate



Biotechnologies


Sort by : relevance - date - popularity
+Vote!

Mentice, Inc. and Education Management Solutions, Inc. Form OEM Partnership

EVANSTON, Ill. and Exton, Pa., Oct. 12 /PRNewswire/ -- Mentice, Inc., a leading developer and supplier of virtual reality (VR) based medical simulation systems and Education Management Solutions, Inc. (EMS), a leader in clinical skills training and evaluation software solutions, today announced at the Transcatheter Cardiovascular Therapeutics symposium in Washington D.C., an OEM partnership that enables...

1Vote!
+Vote!

Big Pharma Embraces the Contentious Cancer Business

Pharmaceutical giants face a conundrum, as illustrated by two recent events. Eli Lilly ( LLY ) agreed to pay $6.5 billion in cash for ImClone Systems ( IMCL ) to get its hands on a roster of experimental cancer drugs. And Roche, bowing to pressure from Britain's National Institute for Health & Clinical Excellence, slashed the price of lung cancer drug Tarceva by $1,200 to $10,830 per four-month course...

1Vote!

MedImmune Presents Data at AAP National Conference & Exhibition Demonstrating Burden of RSV Disease

MedImmune announced today it will present four abstracts at the American Academy of Pediatrics (AAP) 2008 National Conference & Exhibition that add to the company's growing body of research into the prevention of respiratory syncytial virus (RSV), a leading cause of viral respiratory infection among preterm infants.

+Vote!

Amgen v. Hoffmann-LaRoche: Back to the District Court

By Kevin E. Noonan -- The Federal Circuit today issued an Order, pursuant to Federal Rule of Appellate Procedure 36, affirming the District Court's grant of a preliminary injunction in Amgen Inc. v. F. Hoffmann-La Roche Ltd., Amgen's patent infringement suit over Roche's Mircera® drug product. The District Court, having granted the preliminary injunction on February 28, 2008, after a jury verdict that...

+Vote!

XTENT Announces Clinical Trial Data to be Presented at Annual Meeting of Transcatheter Cardiovascular Therapeutics Next Week

WASHINGTON and MENLO PARK, Calif., Oct. 10 /PRNewswire-FirstCall/ -- XTENT, Inc. (Nasdaq: ) today announced that it plans to present long-term follow-up data from the CUSTOM I, II and III clinical trials next week at the Cardiovascular Research Foundation's (CRF) twentieth annual Transcatheter Cardiovascular Therapeutics (TCT) meeting in Washington, DC. The CUSTOM clinical trials are prospective studies...

+Vote!

Two new PDL directors get cash, options

PDL BioPharma Inc. named two biotech and medical device veterans to its board, giving them baseline $35,000 annual cash retainers, temporary $10,000 monthly cash retainers and options to buy thousands of shares. (ANSV) (DNA) (BSX) (PDLI)

1Vote!

Amgen Issues Statement on Court of Appeals Ruling That Affirms Preliminary Injunction Against Roche

THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Today the United States (U.S.) Court of Appeals for the Federal Circuit issued a ruling that affirms the preliminary injunction ordered by the U.S.

+Vote!

PDL BioPharma: PDL BioPharma Elects Paul Sandman and John McLaughlin to Its Board of Directors

REDWOOD CITY, CA (MARKET WIRE) PDL BioPharma, Inc. (NASDAQ: PDLI) today announced the election of Paul W. Sandman and John P. McLaughlin to the company's board of directors.

+Vote!

Neurobiological Technologies Announces Update Call on Viprinex (TM) Phase 3 Trial Program

EMERYVILLE, Calif., Oct. 10 /PRNewswire-FirstCall/ -- Neurobiological Technologies, Inc. (NTI(R)) (Nasdaq: ), today announced it will hold a conference call on Monday, October 13, to provide an update on the Viprinex(TM) (ancrod) Phase 3 Trial Program for acute ischemic stroke. Hosting the call will be Paul E. Freiman, president and chief executive officer and Warren W. Wasiewski, chief medical officer. ...

+Vote!
+Vote!

Former MedImmune head analyzes liquidity drought

In sizing up the credit crisis and the impact it has had and will have on the biotechnology industry, David Mott voiced a sliver of good hope. His message: It has happened before.

+Vote!

New Study Finds Growth Factor Boosts Productivity in Mammalian Cell Culture

Leading researchers in academia and industry reveal powerful effects of recombinant lactoferrin (tradename: Lacromin) in mammalian cell culture leading to a significant boost in productivity. FORT COLLINS, Colo., Oct. 10 /PRNewswire/ -- A recently published study in the scientific journal In Vitro Cellular & Developmental Biology revealed that recombinant lactoferrin (tradename: Lacromin, see )...

2Vote!

Survey ranks top biotech, biopharma employers

Science announced the results of its annual Top Employers survey. After placing second last year, Genentech once again claimed the top spot for the sixth year. Missouri-based Monsanto climbed six spots to come in at number two this year, with Genzyme rounding out the top three. The annual web-based survey, now in its seventh year, polls employees of biotech, biopharma and pharmaceutical companies,...

1Vote!

Synageva BioPharma Appoints Leading Clinician and Industry Executive, Dr. Mark Goldberg, to Its Board of Directors

Synageva BioPharma announced today the appointment of Mark Goldberg, M.D., Senior Vice President of Clinical Research at Genzyme Corp., and a leading medical oncologist and hematologist, to the Company's Board of Directors.